HUP0301964A3 - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- HUP0301964A3 HUP0301964A3 HU0301964A HUP0301964A HUP0301964A3 HU P0301964 A3 HUP0301964 A3 HU P0301964A3 HU 0301964 A HU0301964 A HU 0301964A HU P0301964 A HUP0301964 A HU P0301964A HU P0301964 A3 HUP0301964 A3 HU P0301964A3
- Authority
- HU
- Hungary
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25250800P | 2000-11-22 | 2000-11-22 | |
| PCT/US2001/051647 WO2003053331A2 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0301964A2 HUP0301964A2 (en) | 2007-02-28 |
| HUP0301964A3 true HUP0301964A3 (en) | 2007-09-28 |
Family
ID=22956303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0301964A HUP0301964A3 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1392657A4 (en) |
| JP (1) | JP2005513083A (en) |
| KR (1) | KR20040004445A (en) |
| CN (1) | CN1635903A (en) |
| AR (1) | AR034278A1 (en) |
| AU (1) | AU2001298052A1 (en) |
| BR (1) | BR0115473A (en) |
| CA (1) | CA2436850A1 (en) |
| CZ (1) | CZ20031403A3 (en) |
| HU (1) | HUP0301964A3 (en) |
| IL (1) | IL155997A0 (en) |
| MX (1) | MXPA03004542A (en) |
| NO (1) | NO20032328L (en) |
| PL (1) | PL366232A1 (en) |
| UY (1) | UY27032A1 (en) |
| WO (1) | WO2003053331A2 (en) |
| ZA (1) | ZA200303848B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| NZ520588A (en) | 2000-03-21 | 2004-06-25 | Smithkline Beecham Corp | Protease inhibitors |
| WO2001095911A1 (en) * | 2000-06-14 | 2001-12-20 | Smithkline Beecham Corporation | Protease inhibitors |
| KR20100023948A (en) | 2007-06-08 | 2010-03-04 | 닛뽕 케미파 가부시키가이샤 | Therapeutic or prophylactic agent for cerebral aneurysm |
| WO2009054454A1 (en) | 2007-10-24 | 2009-04-30 | National University Corporation Tokyo Medical And Dental University | Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0104768A3 (en) * | 1998-12-23 | 2002-05-28 | Smithkline Beecham Corp | 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same |
| NZ520588A (en) * | 2000-03-21 | 2004-06-25 | Smithkline Beecham Corp | Protease inhibitors |
| WO2001095911A1 (en) * | 2000-06-14 | 2001-12-20 | Smithkline Beecham Corporation | Protease inhibitors |
-
2001
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/en unknown
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/en unknown
- 2001-11-19 PL PL01366232A patent/PL366232A1/en not_active Application Discontinuation
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/en not_active Withdrawn
- 2001-11-19 IL IL15599701A patent/IL155997A0/en unknown
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/en not_active Application Discontinuation
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/en unknown
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/en not_active Application Discontinuation
- 2001-11-19 CN CNA018220533A patent/CN1635903A/en active Pending
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-20 AR ARP010105409A patent/AR034278A1/en unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/en not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03004542A (en) | 2003-09-10 |
| NO20032328D0 (en) | 2003-05-22 |
| EP1392657A2 (en) | 2004-03-03 |
| KR20040004445A (en) | 2004-01-13 |
| EP1392657A4 (en) | 2004-03-10 |
| CZ20031403A3 (en) | 2003-10-15 |
| UY27032A1 (en) | 2002-07-31 |
| AR034278A1 (en) | 2004-02-18 |
| BR0115473A (en) | 2004-09-28 |
| WO2003053331A2 (en) | 2003-07-03 |
| NO20032328L (en) | 2003-07-02 |
| CN1635903A (en) | 2005-07-06 |
| CA2436850A1 (en) | 2003-07-03 |
| AU2001298052A1 (en) | 2003-07-09 |
| ZA200303848B (en) | 2004-06-28 |
| HUP0301964A2 (en) | 2007-02-28 |
| IL155997A0 (en) | 2003-12-23 |
| PL366232A1 (en) | 2005-01-24 |
| WO2003053331A3 (en) | 2003-11-13 |
| JP2005513083A (en) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2002002593A0 (en) | Protease inhibitors | |
| GB0125445D0 (en) | Protease Inhibitors | |
| IL215892A0 (en) | Peptidomimetic protease inhibitors | |
| IL153421A0 (en) | Protease inhibitors | |
| EP1235577A4 (en) | Protease inhibitors | |
| EP1232155A4 (en) | Protease inhibitors | |
| IL151087A0 (en) | Protease inhibitors | |
| EP1229912A4 (en) | Protease inhibitors | |
| EP1231921A4 (en) | Protease inhibitors | |
| EP1229915A4 (en) | Protease inhibitors | |
| EP1229914A4 (en) | Protease inhibitors | |
| EP1173429A4 (en) | Protease inhibitors | |
| EP1233771A4 (en) | Protease inhibitors | |
| EP1229911A4 (en) | Protease inhibitors | |
| EP1161237A4 (en) | Protease inhibitors | |
| EP1351930A4 (en) | Protease inhibitors | |
| EP1401453A4 (en) | Protease inhibitors | |
| EP1231923A4 (en) | Protease inhibitors | |
| IL155997A0 (en) | Protease inhibitors | |
| IL155961A0 (en) | Cysteine protease inhibitors | |
| EP1232154A4 (en) | Protease inhibitors | |
| EP1231922A4 (en) | Protease inhibitors | |
| AU6407701A (en) | Serine protease inhibitors | |
| GB0009123D0 (en) | Protease inhibitor | |
| ZA200207478B (en) | Protease inhibitors. |